International College of Angiology

Member, Council for International Organizations of Medical Sciences (CIOMS)

EXECUTIVE OFFICE: 161 MORIN DRIVE,  JAY, VERMONT 05859-9283 U.S.A.
TELEPHONE: +802.988.4065 | Mobile: +516.901.1857
ICA EMAIL: denisemrossignol@cs.com  or ica@intlcollegeofangiology.org

ABSTRACT PROCESSING FEE: A one-time non-refundable abstract processing fee of USD $25 must accompany your abstract submission for Non-Fellows of the International College of Angiology. Those who are Fellows, Associate/Affiliate Fellows, Members and Students of the ICA receive a waiver of this fee as part of their membership benefits. Please refer to the "Online Abstract Processing Fee" section for the payment of your ABSTRACT PROCESSING FEE. Thank you.

THE FOLLOWING FORM MUST BE SUBMITTED WITH YOUR ABSTRACT IN ORDER TO BE CONSIDERED FOR PRESENTATION

ABSTRACTS NOT COMPLYING WITH THE INFORMATION BELOW WILL NOT BE CONSIDERED

Please read the information entirely prior to completing the form.

I have read the policies regarding "Conflict of Interest" and "Off-Label Disclosure" relative to the presentation as submitted and titled below:

Conflict of Interest: A potential conflict of interest exists when there is involvement between the speaker/presenter with any for-profit commercial form or organization (FPC). This includes, but is not limited to, one or more of the following: consultant, scientific advisory committee member, or lecturer for a FPC from which income is derived; officer, board member, trustee, owner or employee of an FPC; stock or bond holdings in an FPC (investments entirely managed by a third party such as mutual funds and pension plans are excluded); stock options held in an FPC.

Off-Label Disclosure (Including Generic Trade Names and Reporting Scientific Research): Presentations must give a balanced view of options. Faculty use of generic names will contribute to this impartiality. Presentations supported by any commercial entity reporting the results of scientific research must conform to the generally accepted standards of experimental design, data collection and analysis. When an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose is being discussed during an educational activity, it is required that the speaker disclose that the product is not labeled for the use under discussion or that the product is still investigational.

The Importance of Identification: In order for the audience at a presentation sponsored by the International College of Angiology to evaluate information, analysis and opinions presented during the meeting, it is crucial that the audience be informed of any aspect of the speaker's personal or professional affiliations that may reasonably affect the presenter's view prior to the presentation(s). (For instance, affiliation with the manufacturer of a drug or device related to the topic). Additionally, faculty members are required to report if their presentation includes discussion(s) of investigational products or products not labeled for use.

CONFLICT OF INTEREST & OFF-LABEL DISCLOSURE POLICIES & FORM